These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Pathways responsible for platelet hypersensitivity in rats with diabetes. I. Streptozocin-induced diabetes. Winocour PD; Kinlough-Rathbone RL; Mustard JF J Lab Clin Med; 1986 Feb; 107(2):148-53. PubMed ID: 3080538 [TBL] [Abstract][Full Text] [Related]
25. Platelet aggregation measured in rabbit whole blood: in vitro study of 3 aggregating agents and ex vivo inhibition by aspirin and ticlopidine. Chevolet C; Grosdent JC; Reiters GM; Dresse A Arch Int Pharmacodyn Ther; 1982 Oct; 259(2):310-1. PubMed ID: 6817725 [No Abstract] [Full Text] [Related]
26. Experimental diabetes and platelet aggregation in the rat. Murray J; Kaneko JJ; Rucker RB Res Commun Chem Pathol Pharmacol; 1983 Aug; 41(2):283-91. PubMed ID: 6356254 [TBL] [Abstract][Full Text] [Related]
27. Time course of changes in in vitro platelet function and plasma von willebrand factor activity (VIIIR:WF) and factor VIII-related antigen (VIIIR:Ag) in the diabetic rat. Winocour PD; Lopes-Virella M; Laimins M; Colwell JA J Lab Clin Med; 1983 Nov; 102(5):795-804. PubMed ID: 6415193 [TBL] [Abstract][Full Text] [Related]
28. Functionally thrombasthenic state in normal platelets following the administration of ticlopidine. Di Minno G; Cerbone AM; Mattioli PL; Turco S; Iovine C; Mancini M J Clin Invest; 1985 Feb; 75(2):328-38. PubMed ID: 3156146 [TBL] [Abstract][Full Text] [Related]
29. Effects of ticlopidine on thrombotic obstruction of A-V shunts and on dialysance of artificial kidneys. Maeda K; Usuda M; Kawaguchi S; Shinzato T; Saito A; Ohta K; Kobayashi K; Ohbayashi S; Narita M Artif Organs; 1980 Feb; 4(1):30-3. PubMed ID: 7369892 [TBL] [Abstract][Full Text] [Related]
30. Ticlopidine in the secondary prevention of early diabetes-related microangiopathy: protocol of a multicenter therapeutic study (TIMAD study). Mirouze J Agents Actions Suppl; 1984; 15():230-58. PubMed ID: 6385649 [No Abstract] [Full Text] [Related]
34. A platelet aggregation inhibitor--ticlopidine--in diabetic nephropathy: a randomized double blind study. Nyberg G; Larsson O; Westberg NG; Aurell M; Jagenburg R; Blohmé G Clin Nephrol; 1984 Mar; 21(3):184-7. PubMed ID: 6705280 [TBL] [Abstract][Full Text] [Related]
35. Repeat oral dosing of prasugrel, a novel P2Y12 receptor inhibitor, results in cumulative and potent antiplatelet and antithrombotic activity in several animal species. Niitsu Y; Sugidachi A; Ogawa T; Jakubowski JA; Hashimoto M; Isobe T; Otsuguro K; Asai F Eur J Pharmacol; 2008 Jan; 579(1-3):276-82. PubMed ID: 17996866 [TBL] [Abstract][Full Text] [Related]
36. Ticlopidine treatment reduces the progression of nonproliferative diabetic retinopathy. The TIMAD Study Group. Arch Ophthalmol; 1990 Nov; 108(11):1577-83. PubMed ID: 2244843 [TBL] [Abstract][Full Text] [Related]
37. [Platelet aggregation from interaction between washed platelets and purified thrombin, plasmin or trypsin (author's transl)]. Matsuoka M; Watanabe T; Koike K; Sakuragawa N Rinsho Ketsueki; 1974 May; 15(5):519-23. PubMed ID: 4277899 [No Abstract] [Full Text] [Related]
38. [Dose-effect relationship of traditional Chinese medicine formula for promoting blood circulation to remove stasis on ADP-induced platelet aggregation and rabbit plasma thrombin time]. Zhang Y; Tang Y; Guo J; Ding A; Duan J Zhongguo Zhong Yao Za Zhi; 2009 Nov; 34(21):2821-6. PubMed ID: 20209924 [TBL] [Abstract][Full Text] [Related]
39. Effect of insulin treatment in streptozocin-induced diabetic rats on in vitro platelet function and plasma von Willebrand factor activity and factor VIII-related antigen. Winocour PD; Lopes-Virella M; Laimins M; Colwell JA J Lab Clin Med; 1985 Sep; 106(3):319-25. PubMed ID: 3928783 [TBL] [Abstract][Full Text] [Related]
40. Effect of aspirin on prostanoids and nitric oxide production in streptozotocin-diabetic rats with ischemic retinopathy. De La Cruz P; Guerrero A; Paniego J; Arranz I; Moreno A; Sánchez De La Cuesta F Naunyn Schmiedebergs Arch Pharmacol; 2002 Feb; 365(2):96-101. PubMed ID: 11819026 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]